524314 — Gujarat Terce Laboratories Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹326.49m
- IN₹302.58m
- IN₹501.95m
- 46
- 70
- 13
- 37
Annual cashflow statement for Gujarat Terce Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -25.3 | 7.47 | -28.9 | 5.44 | 33.9 |
| Depreciation | |||||
| Non-Cash Items | 3.97 | 3.21 | 6.53 | 3.96 | 1.48 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 17.8 | -17.9 | 19 | 12.9 | -8.64 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -1.75 | -4.43 | 0.267 | 26 | 30.6 |
| Capital Expenditures | -5.04 | -21.1 | -0.631 | -0.737 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.807 | -2.54 | 6.78 | -3.84 | 4.55 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -4.24 | -23.7 | 6.15 | -4.58 | 4.55 |
| Financing Cash Flow Items | -2.98 | -4.01 | -7.21 | -6.76 | 0.997 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 18.4 | 15.3 | -1.21 | -40.8 | -28.3 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 12.4 | -12.8 | 5.21 | -19.4 | 6.89 |